Page 64 - GlaxoSmithKline Pharmaceuticals AR 2012

60
Statement pursuant to Section 212 of the Companies Act, 1956
Name of the
subsidiary company
Financial year
ending of the
subsidiary
Number of
equity
shares held
Extent of
holding
For the financial year
of the subsidiary
For the previous financial years
since it became a subsidiary
Profits/(losses)
so far as it
concerns the
members of
the holding
company and
not dealt with
in the holding
company’s
accounts.
Profits/(losses)
so far as it
concerns the
members of
the holding
company and
dealt with in
the holding
company’s
accounts.
Profits/(losses)
so far as it
concerns the
members of
the holding
company and
not dealt with
in the holding
company’s
accounts.
Profits/(losses)
so far as it
concerns the
members of
the holding
company and
dealt with in
the holding
company’s
accounts.
Rs. lakhs Rs. lakhs Rs. lakhs Rs. lakhs
Biddle Sawyer Limited 31.12.2012 9,60,000 shares
of Rs. 10 each
100% 6,62.15 — 121,01.23 —
For and on behalf of the Board
Vice-Chairman V. Thyagarajan
Managing Director Dr. H. B. Joshipura
Senior Executive Director M. B. Kapadia
Mumbai, 19th February, 2013 Company Secretary A. A. Nadkarni